Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up
- Status
- COMPLETED
- Phase
- PHASE4
RAD001 Plus Bevacizumab in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection
- Status
- TERMINATED
- Phase
- PHASE2
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
- Status
- TERMINATED
- Phase
- PHASE2
Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Safe Renal Function In Long Term Heart Transplanted Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE3
Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2